NasdaqCM - Delayed Quote USD
enGene Holdings Inc. (ENGN)
4.0000
+0.0100
+(0.25%)
At close: 4:00:01 PM EDT
Breakdown
TTM
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Operating Cash Flow
-66,607
-48,281
-24,743
-17,592
-15,984
Investing Cash Flow
-210,411
-125,953
-318
-153
-247
Financing Cash Flow
253,717
265,716
86,147
27,967
22,525
End Cash Position
62,345
173,004
81,521
20,434
11,017
Interest Paid Supplemental Data
2,174
1,925
1,398
615
--
Capital Expenditure
-718
-925
-318
-153
-248
Issuance of Capital Stock
--
260,149
56,892
--
15,601
Issuance of Debt
--
22,500
38,000
29,400
8,032
Repayment of Debt
--
-9,445
-4,731
-1,010
-964
Free Cash Flow
-67,325
-49,206
-25,061
-17,745
-16,232
10/31/2021 - 2/1/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
7R8.BE Replimune Group Inc
7.70
0.00%
NXOA.BE Nicox SA
0.2260
0.00%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
0M4.DU Mersana Therapeutics Inc
0.3367
-0.41%
GON.DU Geron Corp
1.2265
+0.20%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
OCD1.MU ChromaDex Corp
6.20
+3.33%
300759.SZ Pharmaron Beijing Co., Ltd.
23.08
+1.58%